Keyphrases
In Vivo Characterization
100%
Serotonin-dopamine Activity Modulators
100%
Brexpiprazole
100%
D2 Receptor
37%
High Affinity
25%
D2 Partial Agonist
25%
Agonist Activity
25%
Dopamine
25%
Inhibitory Effect
12%
Prefrontal Cortex
12%
Psychiatric Disorders
12%
Treatment Options
12%
Receptor Antagonist
12%
Receptor Agonist
12%
Binding Affinity
12%
Clinical Development
12%
Adverse Effects
12%
Antagonism
12%
Antipsychotics
12%
Aripiprazole
12%
Serotonin
12%
Pharmacology
12%
Novel Treatments
12%
Microdialysis
12%
5-HT1A
12%
Phenylacetic Acid
12%
Serotonin 2A Receptor (5-HT2AR)
12%
5-HT1A Receptor
12%
Noradrenaline
12%
5-HT2A Receptor
12%
Nucleus Accumbens
12%
Receptor Binding
12%
Binding Studies
12%
Reserpine
12%
Intrinsic Activity
12%
OPC-34712
12%
Binding Potency
12%
2,5-dimethoxy-4-iodoamphetamine
12%
Dopamine Metabolites
12%
Novel Drug Candidates
12%
Nervous System Diseases
12%
Head Twitch
12%
Quinolin-2-one
12%
Homovanillic Acid
12%
Pharmacology, Toxicology and Pharmaceutical Science
Serotonin
100%
Brexpiprazole
100%
Receptor
55%
Partial Agonist
22%
Adverse Event
11%
Receptor Agonist
11%
Receptor Antagonist
11%
Noradrenalin
11%
Antipsychotic
11%
Aripiprazole
11%
Microdialysis
11%
2,5-Dimethoxy-4-iodoamphetamine
11%
Central Nervous System Disease
11%
Potassium Acetate
11%
Intrinsic Activity
11%
Homovanillic Acid
11%
DOPA
11%
Head Twitch
11%
Reserpine
11%